The Securities and Exchange Board of India banned the chief financial officer of drug maker Wockhardt from capital-markets activities for 18 months., more
Tuesday, April 28, 2009
Subscribe to:
Post Comments (Atom)
The lastest news and observations about doing business in Asia.
No comments:
Post a Comment